jueves, 20 de junio de 2024

Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma Posted: June 19, 2024

https://www.cancer.gov/news-events/press-releases/2024/vipor-combination-therapy-b-cell-lymphoma?cid=eb_govdel

No hay comentarios:

Publicar un comentario